Skip to main content
Top
Published in:

Open Access 01-12-2024 | Review

A systematic review of economic evaluation of healthcare associated infection prevention and control interventions in long term care facilities

Authors: Eric Nguemeleu Tchouaket, Fatima El-Mousawi, Stephanie Robins, Katya Kruglova, Catherine Séguin, Kelley Kilpatrick, Maripier Jubinville, Suzanne Leroux, Idrissa Beogo, Drissa Sia

Published in: Health Economics Review | Issue 1/2024

Login to get access

Abstract

Background

Healthcare-associated infections (HCAI) are common in long-term care facilities (LTCF) and cause significant burden. Infection prevention and control (IPC) measures include the clinical best practices (CBP) of hand hygiene, hygiene and sanitation, screening, and basic and additional precautions. Few studies demonstrate their cost-effectiveness in LTCF, and those that do, largely focus on one CBP. An overarching synthesis of IPC economic analyses in this context is warranted. The aim of this paper is to conduct a systematic review of economic evaluations of CBP applied in LTCF.

Methods

We twice queried CINAHL, Cochrane, EconLit, Embase, Medline, Web of Science and Scopus for studies published in the last three decades of economic evaluations of CBP in LTCF. We included controlled and randomized clinical trials, cohort, longitudinal, follow-up, prospective, retrospective, cross-sectional, and simulations studies, as well as those based on mathematical or statistical modelling. Two reviewers conducted study selection, data extraction, and quality assessment of studies. We applied discounting rates of 3%, 5% and 8%, and presented all costs in 2022 Canadian dollars. The protocol of this review was registered with Research Registry (reviewregistry1210) and published in BMC Systematic Reviews.

Findings

We found 3,331 records and then 822 records; ten studies were retained. The economic analyses described were cost-minimization (n = 1), cost-benefit (n = 1), cost-savings (n = 2), cost-utility (n = 2) and cost-effectiveness which included cost-utility and cost-benefit analyses (n = 4). Four studies were high quality, three were moderate, and three were low quality. Inter-rater agreement for quality assessment was 91⋅7%. All studies (n = 10) demonstrated that CBP associated with IPC are clinically effective in LTCF and many (n = 6) demonstrated their cost effectiveness.

Interpretation

Ongoing economic evaluation research of IPC remains essential to underpin healthcare policy choices guided by empirical evidence for LTCF residents and staff.
Appendix
Available only for authorised users
Literature
2.
go back to reference Montoya A, Cassone M, Mody L. Infections in nursing homes: Epidemiology and Prevention Programs. Clin Geriatr Med. 2016;32(3):585–607.CrossRefPubMed Montoya A, Cassone M, Mody L. Infections in nursing homes: Epidemiology and Prevention Programs. Clin Geriatr Med. 2016;32(3):585–607.CrossRefPubMed
3.
go back to reference Béland D, Marier P. COVID-19 and long-term care policy for older people in Canada. J Aging Soc Policy. 2020;32(4–5):358–64.CrossRefPubMed Béland D, Marier P. COVID-19 and long-term care policy for older people in Canada. J Aging Soc Policy. 2020;32(4–5):358–64.CrossRefPubMed
4.
go back to reference Gardner W, States D, Bagley N. The coronavirus and the risks to the Elderly in Long-Term Care. J Aging Soc Policy. 2020;32(4–5):310–5.CrossRefPubMed Gardner W, States D, Bagley N. The coronavirus and the risks to the Elderly in Long-Term Care. J Aging Soc Policy. 2020;32(4–5):310–5.CrossRefPubMed
5.
go back to reference Vrijens F, Hulstaert F, van de Devriese S. Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs. Epidemiol Infect. 2012;140(1):126–36.CrossRefPubMed Vrijens F, Hulstaert F, van de Devriese S. Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs. Epidemiol Infect. 2012;140(1):126–36.CrossRefPubMed
6.
go back to reference Gidey K, Gidey MT, Hailu BY, Gebreamlak ZB, Niriayo YL. Clinical and economic burden of healthcare-associated infections: a prospective cohort study. PLoS ONE. 2023;18(2):e0282141.CrossRefPubMedPubMedCentral Gidey K, Gidey MT, Hailu BY, Gebreamlak ZB, Niriayo YL. Clinical and economic burden of healthcare-associated infections: a prospective cohort study. PLoS ONE. 2023;18(2):e0282141.CrossRefPubMedPubMedCentral
7.
go back to reference Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Eurosurveillance. 2018;23(46):1800516.CrossRefPubMedPubMedCentral Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Eurosurveillance. 2018;23(46):1800516.CrossRefPubMedPubMedCentral
8.
go back to reference Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011;32(2):101–14.CrossRefPubMed Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011;32(2):101–14.CrossRefPubMed
10.
go back to reference Hazra NC, Rudisill C, Gulliford MC. Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or proximity to death? Eur J Health Econ. 2018;19(6):831–42.CrossRefPubMed Hazra NC, Rudisill C, Gulliford MC. Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or proximity to death? Eur J Health Econ. 2018;19(6):831–42.CrossRefPubMed
11.
go back to reference Finger HJ, Rao RN, Sansone GR, Hazel EJ, Silvestri-Tan CT. Newly developed COVID-19 bundle greatly reduces the infection fatality rate for a highly vulnerable nursing Home Population. Am J Med Qual. 2022;37(1):46–54.CrossRefPubMed Finger HJ, Rao RN, Sansone GR, Hazel EJ, Silvestri-Tan CT. Newly developed COVID-19 bundle greatly reduces the infection fatality rate for a highly vulnerable nursing Home Population. Am J Med Qual. 2022;37(1):46–54.CrossRefPubMed
12.
go back to reference Rennert-May E, Conly J, Leal J, Smith S, Manns B. Economic evaluations and their use in infection prevention and control: a narrative review. Antimicrob Resist Infect Control. 2018;7(1):31.CrossRefPubMedPubMedCentral Rennert-May E, Conly J, Leal J, Smith S, Manns B. Economic evaluations and their use in infection prevention and control: a narrative review. Antimicrob Resist Infect Control. 2018;7(1):31.CrossRefPubMedPubMedCentral
13.
go back to reference Rice S, Carr K, Sobiesuo P, Shabaninejad H, Orozco-Leal G, Kontogiannis V, et al. Economic evaluations of interventions to prevent and control health-care-associated infections: a systematic review. Lancet Infect Dis. 2023;23(7):e228–39.CrossRefPubMed Rice S, Carr K, Sobiesuo P, Shabaninejad H, Orozco-Leal G, Kontogiannis V, et al. Economic evaluations of interventions to prevent and control health-care-associated infections: a systematic review. Lancet Infect Dis. 2023;23(7):e228–39.CrossRefPubMed
14.
go back to reference Tchouaket Nguemeleu E, Beogo I, Sia D, Kilpatrick K, Séguin C, Baillot A, et al. Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: systematic review using a discounting approach. J Hosp Infect. 2020;106(1):134–54.CrossRefPubMedPubMedCentral Tchouaket Nguemeleu E, Beogo I, Sia D, Kilpatrick K, Séguin C, Baillot A, et al. Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: systematic review using a discounting approach. J Hosp Infect. 2020;106(1):134–54.CrossRefPubMedPubMedCentral
15.
go back to reference Cohen CC, Choi YJ, Stone PW. Costs of infection Prevention practices in Long-Term Care settings: a systematic review. Nurs Econ. 2016;34(1):16–24.PubMedPubMedCentral Cohen CC, Choi YJ, Stone PW. Costs of infection Prevention practices in Long-Term Care settings: a systematic review. Nurs Econ. 2016;34(1):16–24.PubMedPubMedCentral
16.
go back to reference Herrera Diaz M, Haworth-Brockman M, Keynan Y. Review of evidence for using chest X-rays for active tuberculosis screening in long-term care in Canada. Front Public Health. 2020;8:16.CrossRefPubMedPubMedCentral Herrera Diaz M, Haworth-Brockman M, Keynan Y. Review of evidence for using chest X-rays for active tuberculosis screening in long-term care in Canada. Front Public Health. 2020;8:16.CrossRefPubMedPubMedCentral
17.
go back to reference Tchouaket EN, Kruglova K, Beogo I, Sia D, Robins S, Bélanger E, et al. Economic evaluation of healthcare-associated infection prevention and control in long-term care: a systematic review protocol. Syst Reviews. 2022;11(1):261.CrossRef Tchouaket EN, Kruglova K, Beogo I, Sia D, Robins S, Bélanger E, et al. Economic evaluation of healthcare-associated infection prevention and control in long-term care: a systematic review protocol. Syst Reviews. 2022;11(1):261.CrossRef
18.
go back to reference Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.CrossRefPubMedPubMedCentral Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.CrossRefPubMedPubMedCentral
19.
go back to reference CADTH. Guidelines for the Economic Evaluation of Health Technologies: Canada (4th Edition). CADTH; 2017. CADTH. Guidelines for the Economic Evaluation of Health Technologies: Canada (4th Edition). CADTH; 2017.
20.
go back to reference Resar R, Griffin FA, Haraden C, Nolan TW. Using Care Bundles to Improve Health Care Quality. 2012. Resar R, Griffin FA, Haraden C, Nolan TW. Using Care Bundles to Improve Health Care Quality. 2012.
21.
go back to reference Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Reviews. 2016;5(1):210.CrossRef Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Reviews. 2016;5(1):210.CrossRef
22.
go back to reference Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMC Med. 2013;11(1):80.CrossRefPubMedPubMedCentral Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMC Med. 2013;11(1):80.CrossRefPubMedPubMedCentral
23.
go back to reference Scottish Intercollegiate Guidelines N. SIGN 50: a guideline developer’s handbook. Edinburgh, UK: SIGN; 2019 2019. Scottish Intercollegiate Guidelines N. SIGN 50: a guideline developer’s handbook. Edinburgh, UK: SIGN; 2019 2019.
24.
go back to reference Drummond M. Methods for the economic evaluation of health care programmes. Fourth edition ed. Oxford, United Kingdom ; New York, NY, USA: Oxford University Press; 2015 2015. 445 p. Drummond M. Methods for the economic evaluation of health care programmes. Fourth edition ed. Oxford, United Kingdom ; New York, NY, USA: Oxford University Press; 2015 2015. 445 p.
25.
go back to reference Cochrane Handbook for Systematic Reviews. of Interventions version 6.3 (updated February 2022): Cochrane; 2022 2022. Cochrane Handbook for Systematic Reviews. of Interventions version 6.3 (updated February 2022): Cochrane; 2022 2022.
26.
go back to reference Institute TJB. Joanna Briggs Institute Reviewers’ Manual: 2014 edition/supplement. The Joanna Briggs Institute; 2014. Institute TJB. Joanna Briggs Institute Reviewers’ Manual: 2014 edition/supplement. The Joanna Briggs Institute; 2014.
27.
go back to reference Marchand R, Tousignant P, Chang H. Cost-effectiveness of screening compared to case-finding approaches to tuberculosis in long-term care facilities for the elderly. Int J Epidemiol. 1999;28(3):563–70.CrossRefPubMed Marchand R, Tousignant P, Chang H. Cost-effectiveness of screening compared to case-finding approaches to tuberculosis in long-term care facilities for the elderly. Int J Epidemiol. 1999;28(3):563–70.CrossRefPubMed
28.
go back to reference Church DL, Davies HD, Mitton C, Semeniuk H, Logue M, Maxwell C, et al. Clinical and economic evaluation of rapid influenza a virus testing in nursing homes in Calgary, Canada. Clin Infect Dis. 2002;34(6):790–5.CrossRefPubMed Church DL, Davies HD, Mitton C, Semeniuk H, Logue M, Maxwell C, et al. Clinical and economic evaluation of rapid influenza a virus testing in nursing homes in Calgary, Canada. Clin Infect Dis. 2002;34(6):790–5.CrossRefPubMed
29.
go back to reference Trick WE, Weinstein RA, DeMarais PL, Tomaska W, Nathan C, McAllister SK, et al. Comparison of routine glove use and contact-isolation precautions to prevent transmission of multidrug-resistant bacteria in a long-term care facility. J Am Geriatr Soc. 2004;52(12):2003–9.CrossRefPubMed Trick WE, Weinstein RA, DeMarais PL, Tomaska W, Nathan C, McAllister SK, et al. Comparison of routine glove use and contact-isolation precautions to prevent transmission of multidrug-resistant bacteria in a long-term care facility. J Am Geriatr Soc. 2004;52(12):2003–9.CrossRefPubMed
30.
go back to reference Verma G, Chuck AW, Jacobs P. Tuberculosis screening for long-term care: a cost-effectiveness analysis. Int J Tuberc Lung Dis. 2013;17(9):1170–7.CrossRefPubMed Verma G, Chuck AW, Jacobs P. Tuberculosis screening for long-term care: a cost-effectiveness analysis. Int J Tuberc Lung Dis. 2013;17(9):1170–7.CrossRefPubMed
31.
go back to reference Hutton DW, Krein SL, Saint S, Graves N, Kolli A, Lynem R, et al. Economic evaluation of a Catheter-Associated Urinary Tract Infection Prevention Program in nursing homes. J Am Geriatr Soc. 2018;66(4):742–7.CrossRefPubMedPubMedCentral Hutton DW, Krein SL, Saint S, Graves N, Kolli A, Lynem R, et al. Economic evaluation of a Catheter-Associated Urinary Tract Infection Prevention Program in nursing homes. J Am Geriatr Soc. 2018;66(4):742–7.CrossRefPubMedPubMedCentral
32.
go back to reference Li J, Yip BHK, Leung C, Chung W, Kwok KO, Chan EYY, et al. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: a cost-effectiveness analysis in an intermediate disease burden area. PLoS ONE. 2018;13(1):e0189531.CrossRefPubMedPubMedCentral Li J, Yip BHK, Leung C, Chung W, Kwok KO, Chan EYY, et al. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: a cost-effectiveness analysis in an intermediate disease burden area. PLoS ONE. 2018;13(1):e0189531.CrossRefPubMedPubMedCentral
33.
go back to reference Campbell JR, Uppal A, Oxlade O, Fregonese F, Bastos ML, Lan Z, et al. Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs. CMAJ. 2020;192(40):E1146–55.CrossRefPubMedPubMedCentral Campbell JR, Uppal A, Oxlade O, Fregonese F, Bastos ML, Lan Z, et al. Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs. CMAJ. 2020;192(40):E1146–55.CrossRefPubMedPubMedCentral
34.
go back to reference Lee BY, Bartsch SM, Hayden MK, Welling J, Mueller LE, Brown ST, et al. How to choose target facilities in a region to implement carbapenem-resistant Enterobacteriaceae control measures. Clin Infect Dis. 2021;72(3):438–47.CrossRefPubMed Lee BY, Bartsch SM, Hayden MK, Welling J, Mueller LE, Brown ST, et al. How to choose target facilities in a region to implement carbapenem-resistant Enterobacteriaceae control measures. Clin Infect Dis. 2021;72(3):438–47.CrossRefPubMed
35.
go back to reference Salmerón S, López-Escribano A, García-Nogueras I, Lorenzo J, Romero JM, Hernández-Martínez A et al. Efficiency of Diagnostic Test for SARS-CoV-2 in a nursing home. Geriatr [Internet]. 2022; 7(4). Salmerón S, López-Escribano A, García-Nogueras I, Lorenzo J, Romero JM, Hernández-Martínez A et al. Efficiency of Diagnostic Test for SARS-CoV-2 in a nursing home. Geriatr [Internet]. 2022; 7(4).
36.
go back to reference Sansone GR, Bravo E. Novel care bundle of established basic and practical approaches greatly reduces urinary tract infections in nursing facility residents without indwelling catheters. Am J Infect Control. 2023;51(6):699–704.CrossRefPubMed Sansone GR, Bravo E. Novel care bundle of established basic and practical approaches greatly reduces urinary tract infections in nursing facility residents without indwelling catheters. Am J Infect Control. 2023;51(6):699–704.CrossRefPubMed
Metadata
Title
A systematic review of economic evaluation of healthcare associated infection prevention and control interventions in long term care facilities
Authors
Eric Nguemeleu Tchouaket
Fatima El-Mousawi
Stephanie Robins
Katya Kruglova
Catherine Séguin
Kelley Kilpatrick
Maripier Jubinville
Suzanne Leroux
Idrissa Beogo
Drissa Sia
Publication date
01-12-2024
Publisher
Springer Berlin Heidelberg
Published in
Health Economics Review / Issue 1/2024
Electronic ISSN: 2191-1991
DOI
https://doi.org/10.1186/s13561-024-00582-8